Please use this identifier to cite or link to this item:
|Title:||Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients.|
|Citation:||Kidney Int Rep.2018 Jan;(3)1:122-132|
|Abstract:||Secondary hyperparathyroidism (SHPT) and vitamin D deficiency are common at kidney transplantation and are associated with some early and late complications. This study was designed to evaluate whether paricalcitol was more effective than nutritional vitamin D for controlling SHPT in de novo kidney allograft recipients.|
|Appears in Collections:||Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.